Acerta Pharma

Acerta Pharma, an affiliate of AstraZeneca, is at the forefront of advancing care in haematology by developing innovative investigational agents aimed at directly targeting cancer cells and harnessing the immune system to combat cancer. The company focuses on addressing blood cancers with significant unmet needs by enriching its pipeline with first-in-class and best-in-class medicines.

In collaboration with AstraZeneca, Acerta Pharma employs cutting-edge drug discovery techniques to create transformational therapies for patients with hematological malignancies. With a state-of-the-art research and development center in the Netherlands, the company fosters partnerships with academic and commercial entities to enhance its oncology portfolio.

Generated from the website